Court Says Some Donors of Stem Cells Can Be Paid
By Andrew Pollack,
New York Times
| 12. 01. 2011
An appeals court says a law prohibiting payment for donated organs did not apply to stem cells extracted from circulating blood.
A federal appeals court ruling on Thursday could make it easier for patients with diseases like leukemia to find matching bone marrow donors.
The Court of Appeals for the Ninth Circuit said that a federal law prohibiting payment for donated organs did not apply to stem cells extracted from circulating blood.
“The statute does not prohibit compensation for donations of blood and the substances in it, which include peripheral blood stem cells,” Judge Andrew J. Kleinfeld wrote for a unanimous three-judge panel.
The lawsuit was brought against the federal government by a coalition that included patients seeking bone marrow transplants and MoreMarrowDonors.org, a nonprofit group that wants to offer donors $3,000 in scholarships, housing allowances or gifts to charities.
“Every year, nearly 3,000 Americans die because they cannot find a matching bone marrow donor,” Jeff Rowes, a lawyer at the Institute for Justice, which represented the plaintiffs, said. “Today’s decision will put a stop to this irrational prohibition...
Related Articles
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...